Price Transparency: Charge Master
Standard charges for UC Davis Health services are made available here for your review. This listing of average charges is called the “charge master.” Hospital pricing is complex, in part because most health insurers require significant discounts in the prices they pay for their members’ services as part of agreeing to a contract with a hospital. In addition, UC Davis Health participates with Medicare and Medicaid programs which stipulate reimbursement rates and patient copay amounts.
For charge master disclosure purposes, the rates listed represent the highest amount charged for the service listed – most people, however, pay less than these listed amounts. Charges are the dollar amount a provider sets for services rendered before negotiated rates and discounts. Charges are not always reflective of the price you will pay for the services provided. In addition, we have provided a listing of services by DRG (Diagnosis-Related Group). A DRG is a patient classification system that standardizes prospective payment to hospitals and encourages cost containment initiatives. This list shows the average total charges by DRG.
- Charge List Report (CSV)
- Charge List Report (HTML)
- Average Charges for Inpatient Cases (CSV)
- Average Charges for Inpatient Cases (HTML)
The information contained in these files is current as of the last upload. Charges are subject to periodic changes.
UC Davis Health offers COVID-19 testing to its patients. The self-pay rate for COVID-19 Molecular PCR test (CPT 87635) which involves the use of a nasal pharyngeal swab to determine if a patient has COVID-19 is $100. The serology test (CPT 86769) is a blood test for IGG and IGM antibodies and the self-pay rate is $42 for each test. These rates are consistent with reimbursement established by the Centers for Medicare and Medicaid Services (CMS).
Patients seeking an estimate of personal liability should contact UC Davis Health Customer Service:
Hours: 8:30 a.m. to 4 p.m., Monday – Friday
* In compliance with Chapter 2 of Division 2, commencing with Section 1339.50 of the California Health and Safety Code, and the Centers for Medicare and Medicaid, Fiscal Year 2019 Inpatient Prospective Payment System Final Rule, 83 Federal Reg. 41144.